Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Darling Ingredients
DAR
$9.83B
| $34.1M | 0.02% |
473,708
-1,487,293
| -76% | -$106M |
|
877
Warby Parker
WRBY
$3.24B
| $34M | 0.02% |
+641,450
| New | +$34.5M |
|
878
Incyte
INCY
$25.9B
| $33.9M | 0.02% |
493,177
+14,511
| +3% | +$1.1M |
|
879
Clean Harbors
CLH
$16.6B
| $33.9M | 0.02% |
326,424
+105,654
| +48% | +$10.4M |
|
|
VMRK
880
Vivmark Residential
VMRK
$25.5B
| $33.7M | 0.02% |
416,740
+63,429
| +18% | +$5.24M |
|
881
PUT
Accenture
ACN
$114B
| $33.7M | 0.02% |
105,300
+50,300
| +91% | +$16.4M |
|
882
Simply Good Foods
SMPL
$970M
| $33.6M | 0.02% |
975,456
+91,120
| +10% | +$3.27M |
|
883
M&T Bank
MTB
$34.9B
| $33.6M | 0.02% |
224,757
-188,645
| -46% | -$26.1M |
|
884
Zimmer Biomet
ZBH
$19.3B
| $33.5M | 0.02% |
235,852
-14,606
| -6% | -$2.15M |
|
885
PUT
Edwards Lifesciences
EW
$52.2B
| $33.5M | 0.02% |
295,900
-5,000
| -2% | -$571K |
|
886
Casey's General Stores
CASY
$31.6B
| $33.5M | 0.02% |
177,621
+145,379
| +451% | +$28.5M |
|
|
X
887
DELISTED
US Steel
X
| $33.5M | 0.02% |
1,523,288
-2,705,486
| -64% | -$67.7M |
|
888
Southern Company
SO
$104B
| $33.4M | 0.02% |
538,947
-757,318
| -58% | -$48.8M |
|
|
889
CALL
Accenture
ACN
$114B
| $33.4M | 0.02% |
104,300
+41,100
| +65% | +$13.4M |
|
890
Sunrun
RUN
$2.15B
| $33.3M | 0.02% |
757,272
-273,200
| -27% | -$13M |
|
|
HZON
891
DELISTED
Horizon Acquisition Corporation II
HZON
| $33.3M | 0.02% |
3,399,690
| – | – |
|
892
Dynatrace
DT
$14.2B
| $33.2M | 0.02% |
468,059
+444,992
| +1,929% | +$29.2M |
|
|
PXD
893
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $33.2M | 0.02% |
199,400
| – | – |
|
894
Howmet Aerospace
HWM
$105B
| $33.1M | 0.02% |
1,061,914
+410,264
| +63% | +$13.2M |
|
895
Dover
DOV
$27.4B
| $33.1M | 0.02% |
213,027
-173,945
| -45% | -$28.8M |
|
896
Cisco
CSCO
$434B
| $33M | 0.02% |
606,082
+375,334
| +163% | +$21.1M |
|
|
STMP
897
CALL
DELISTED
Stamps.com, Inc.
STMP
| $33M | 0.02% |
+100,000
| New | +$31.7M |
|
|
GSKY
898
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $32.9M | 0.02% |
2,947,023
+2,619,970
| +801% | +$20.6M |
|
899
Quanta Services
PWR
$92.7B
| $32.9M | 0.02% |
289,342
+143,205
| +98% | +$14.4M |
|
900
CALL
Otis Worldwide
OTIS
$27.5B
| $32.9M | 0.02% |
+400,000
| New | +$35.2M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.